Form 4 for AGL agilon health, inc.
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001628280-25-016679 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +551.5K | 906.8K | +155% | $0 |
| D | 2025-04-03 | 2025-04-01 | AGL | Sell Steven | CEO, Pres, Dir | A - Grant | $0.00 | +865.4K | 865.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | A | A | 551,471 | $0.00 | 906,781 | D | — | — | (F1) Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. (F2) Includes restricted stock units. |
| 2 | Derivative | Options (Right to buy) | 2025-04-01 | A | A | 865,385 | $0.00 | 865,385 | D | $4.08 · — to 2035-04-01 | 865,385 Common Stock | (F4) Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment. |